Early cutaneous alterations in experimental sepsis by Pseudomonas aeruginosa

Haritini Petropoulou1, Evangelos J Giamarellos-Bourboulis, Nicolaos Kavatzas

  • 1Department of Dermatology and Venereology, University of Athens, Medical School, Athens, Greece.

Dermatology (Basel, Switzerland)
|August 19, 2004
PubMed
Abstract

Insights

Histopathologic skin findings in Pseudomonas aeruginosa sepsis correlate with clinical outcomes. Intensified inflammation and lower tumor necrosis factor alpha (TNF-alpha) were observed with prolonged survival in rabbits.

Area of Science:

  • Microbiology
  • Pathology
  • Immunology

Background:

  • Sepsis caused by Pseudomonas aeruginosa presents a significant clinical challenge.
  • Understanding the correlation between skin histopathology and sepsis progression is crucial for effective treatment.

Purpose of the Study:

  • To investigate the relationship between histopathologic skin findings and the clinical course of sepsis induced by Pseudomonas aeruginosa.
  • To evaluate the impact of different P. aeruginosa isolates on sepsis severity and host response.

Main Methods:

  • Sepsis was induced in 18 rabbits via intravenous infusion of P. aeruginosa.
  • Blood samples were analyzed for tumor necrosis factor alpha (TNF-alpha) and malondialdehyde (MDA).
  • Skin and subcutaneous fat biopsies were collected for histopathological examination and bacterial culture.

Main Results:

  • Survival varied significantly based on the P. aeruginosa isolate, ranging from 0.85 to 11.00 days.
  • Histologic findings included dermal inflammation, vascular changes with polymorphonuclear leukocyte infiltration, and necrobiotic alterations.
  • Elevated serum TNF-alpha was noted with a more virulent isolate, while subcutaneous bacterial load decreased with prolonged survival.

Conclusions:

  • Survival in P. aeruginosa sepsis is linked to specific histopathologic skin changes.
  • Lower TNF-alpha levels and reduced bacterial burden in subcutaneous tissue correlate with longer survival.
  • These findings suggest potential targets for immunomodulatory interventions in sepsis treatment.